1 active not recruiting, 1 unknown. 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow TingBo Liang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| T Cell Receptor Gene-Engineered T Cell Therapy Targeting KRAS Mutations in the Treatment of Subjects With Advanced Solid Tumor NW-301V, NW-301D - Tumor, Solid | Phase 1 | Active not recruiting | TingBo Liang | 18 | 2024-02-01 | 2026-10-15 |
| Duct-to-mucosa Versus Invagination for Pancreaticojejunostomy duct-to-mucosa, invagination, Internal stent - Pancreatic Neoplasms, Biliary Tract Neoplasms | Not applicable | Unknown | TingBo Liang | 100 | 2012-01-01 | 2017-01-26 |
Biliary Tract Neoplasms (1) · Neoplasms (1) · Pancreatic Neoplasms (1)
China (2)